Apotex Health to List on Toronto Stock Exchange in 2026 IPO

7 articles · Updated · Bloomberg · May 28

Apotex Health is going public, with plans to list its shares on the Toronto Stock Exchange.
The move would bring one of Canada's best-known healthcare companies to public markets, marking a notable new listing on the TSX.
The report did not disclose deal size, timing beyond 2026, or pricing details, leaving key terms of the IPO still to come.

Can Apotex Health's TSX listing succeed amid new AI regulations and fierce biotech competition?

Will Apotex Health pivot from affordable generics to high-margin AI drugs after going public?